BioNTech SE (BNTX) Short-term Investments (2018 - 2025)

BioNTech SE has reported Short-term Investments for 8 years, with the latest figure at $9.5 billion in Q4 2025.

• Quarterly Short-term Investments rose 4.32% year-over-year to $9.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.5 billion (up 4.32% YoY) and the FY2025 annual result came in at $9.2 billion, up 1.25% from the prior year.
• Short-term Investments climbed to $9.5 billion in Q4 2025 per BNTX's latest filing, from $5.2 billion in the prior quarter.
• Over five years, Short-term Investments peaked at $9.5 billion in Q4 2025 and troughed at $603118.1 in Q1 2021.
• A 5-year average of $3.6 billion and a median of $3.3 billion in 2023 frame the typical range for Short-term Investments.
• The widest YoY moves for Short-term Investments: up 8906.72% in 2022, down 55.73% in 2022.
• Over 5 years, Short-term Investments stood at $436.5 million in 2021, then slumped by 55.73% to $193.2 million in 2022, then jumped by 2620.16% to $5.3 billion in 2023, then jumped by 72.51% to $9.1 billion in 2024, then increased by 4.32% to $9.5 billion in 2025.
• According to Business Quant data, Short-term Investments over the past three periods registered $9.5 billion, $5.2 billion, and $4.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.